Endo Pharmaceuticals (ENDP) Reports Q3 EPS of $0.64, Beats by 12c

October 30, 2008 9:14 AM EDT Send to a Friend

Endo Pharmaceuticals (NASDAQ: ENDP) reports Q3 EPS ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Endo Pharmaceuticals (ENDP) Reports Q3 EPS of $0.64, Beats by 12c

Member Login

Free News Feed